Report from a National Cancer Institute (USA) Workshop on Quality of Life Assessment in Cancer Clinical Trials

To promote the inclusion of quality of life (QOL) end-points in clinical research on cancer, the National Cancer Institute (USA) sponsored a workshop on QOL assessment in cancer clinical trials in July, 1990. Experts in clinical trials and QOL research formed four working groups to identify current...

Full description

Saved in:
Bibliographic Details
Published in:Quality of life research 1992-06, Vol.1 (3), p.203-210
Main Authors: Nayfield, S G, Ganz, P A, Moinpour, C M, Cella, D F, Hailey, B J
Format: Article
Language:English
Subjects:
Breast cancer
Cancer
Chemotherapy
Clinical trials
Clinical Trials as Topic
Data collection
Data Collection - methods
Data Collection - standards
Experimentation
Humans
National Institutes of Health (U.S.)
Neoplasms - drug therapy
Neoplasms - psychology
Quality Control
Quality of Life
Radiotherapy
Recommendations
Research Design - standards
Special Reports
Statistics
Surveys and Questionnaires - standards
United States
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:To promote the inclusion of quality of life (QOL) end-points in clinical research on cancer, the National Cancer Institute (USA) sponsored a workshop on QOL assessment in cancer clinical trials in July, 1990. Experts in clinical trials and QOL research formed four working groups to identify current areas of cancer treatment in which QOL end-points are most important; to discuss methodologic problems in QOL assessment; to address common problems in implementing clinical studies with QOL end-points; and to consider statistical issues in design, implementation, and data analysis. Recommendations made by the working groups are summarized in this paper.
ISSN:0962-9343
1573-2649
DOI:10.1007/bf00635619